Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|February 18, 2014
Risk estimations and treatment decisions in early stage breast cancer: agreement among oncologists and the impact of the 70-gene signatureC A Drukker, H C van den Hout, G S Sonke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2025
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)L Malorni, S Tyekucheva, A Gombos, et al.
Nature Genetics|March 8, 2011
Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone lossMichael A Simpson, Melita D Irving, Esra Asilmaz, et al.
ESMO Open|March 27, 2026
The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancerC Baldini, A R A Mislang, K-L Cheung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutationsJ Mazieres, C Cropet, L Montané, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2016
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational studyS Delaloge, D Pérol, C Courtinard, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screeningFiona E McRonald, Ghasem Yadegarfar, David R Baldwin, et al.
ESMO Open|April 25, 2021
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohortT Grinda, A Antoine, W Jacot, et al.
JCI Insight|February 9, 2022
Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiencySinéad M McGlacken-Byrne, Ignacio Del Valle, Polona Le Quesne Stabej, et al.
Health Technology Assessment (Winchester, England)|May 26, 2016
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancerJohn K Field, Stephen W Duffy, David R Baldwin, et al.
Pageof 11